FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Certificates

FDA
Registration Date 16 Nov 2016
Share

Afinitor

Medicine Pharmaceuticals Product Number : 0078-0627-51

Antineoplastic Agent

Drug Information

Generic
everolimus
NDC Code
0078-0627-51
Drug Class
MTOR inhibitors
Therapeutic Class
Antineoplastic Agent
Dosage form
tablet
Route of Administration
Oral

Indication

Afinitor (everolimus) is a cancer medicine that interferes with the growth of cancer cells and slows their spread in the body. Afinitor is used to treat certain types of kidney cancer, breast cancer, or brain tumor. Everolimus is usually given after other treatments have been tried without success. Afinitor is also used to treat certain types of advanced or progressive tumors of the stomach, intestines, or pancreas. Afinitor is also used to treat non-cancerous (benign) tumors of the kidney in people with a certain genetic condition called tuberous sclerosis complex.

Benefit

Afinitor had already been shown to benefit certain women with HER2-negative breast cancer, and the results of the current study show that it can also provide a benefit in advanced HER2-positive breast cancer.